These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6100753)

  • 1. Effect of nifedipine and verapamil on alpha-receptor-activation in patients with essential hypertension.
    Fritschka E; Distler A; Lenz T; Kribben A; Schudrowitsch L; Philipp T
    J Hypertens Suppl; 1984 Dec; 2(3):S535-8. PubMed ID: 6100753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
    Schwietzer G; Distler A; Reeck S; Thiede HM; Philipp T
    J Hypertens Suppl; 1983 Dec; 1(2):102-4. PubMed ID: 6400109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.
    Galinier M; Senard JM; Valet P; Boneu B; Galinier F; Montastruc JL
    Arch Int Pharmacodyn Ther; 1989; 301():30-9. PubMed ID: 2576196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
    Brodde OE; Daul A; O'Hara N; Bock KD
    J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem.
    Schulte KL; Laber E; Meyer-Sabellek WA; Distler A; Gotzen R
    J Hypertens Suppl; 1985 Dec; 3(3):S239-41. PubMed ID: 2856818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of alpha 2-adrenoceptor density in normotensive and hypertensive man.
    Fritschka E; Kribben A; Hoyer J; Rothschild M; Thiede HM; Distler A; Philipp T
    J Hypertens Suppl; 1987 Dec; 5(5):S349-52. PubMed ID: 2832574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic.
    Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
    J Hypertens Suppl; 1984 Dec; 2(3):S449-52. PubMed ID: 6599697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil compared with nifedipine in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S363-8. PubMed ID: 6184569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet adrenergic alpha receptors in hypertensive subjects undergoing treatment with calcium antagonists].
    Radaelli A; Caporotondi A; Muggia C; Pompei R; Marchesi E
    Boll Soc Ital Biol Sper; 1990 Jan; 66(1):9-13. PubMed ID: 2157469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-adrenoceptor number and function in platelets from treated and untreated patients with essential hypertension and age- and sex-matched controls.
    Jones CR; Elliott HL; Deighton N; Howie CA; Reid JL
    J Hypertens Suppl; 1985 Dec; 3(3):S153-5. PubMed ID: 2856816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.
    Motulsky HJ; Snavely MD; Hughes RJ; Insel PA
    Circ Res; 1983 Feb; 52(2):226-31. PubMed ID: 6297831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha 2-adrenergic receptors and arterial pressure].
    Senard JM; Valet P; Galinier M; Tran MA; Galinier F; Boneu B; Montastruc JL
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1139-41. PubMed ID: 2554834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.
    Cavero I; Shepperson N; Lefèvre-Borg F; Langer SZ
    Circ Res; 1983 Feb; 52(2 Pt 2):I69-76. PubMed ID: 6131754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of vascular and platelet alpha 2-adrenoceptors in rabbits with perinephritis hypertension.
    Hamilton CA; Howie CA; Reid JL
    J Hypertens; 1988 Apr; 6(4):277-82. PubMed ID: 2897989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of platelet alpha 2-adrenoceptors in human hypertension.
    Continsouza-Blanc D; Elghozi JL; Dausse JP
    J Hypertens Suppl; 1984 Dec; 2(3):S155-7. PubMed ID: 6100735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
    Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
    J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of calcium channel blockers on alpha 1- and alpha 2-adrenoceptor-mediated vascular responsiveness in man.
    Elliott HL; Pasanisi F; Sumner DJ; Reid JL
    J Hypertens Suppl; 1985 Dec; 3(3):S235-7. PubMed ID: 2856817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.